{"id":"envlomet-sr-tablet","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL4591082","moleculeType":"Unknown","molecularWeight":"622.79"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by activating alpha-2 adrenergic receptors in the central nervous system, which helps to reduce pain. This mechanism is thought to be responsible for its analgesic effects.","oneSentence":"Envlomet SR Tablet is a sustained-release formulation of a selective alpha-2 adrenergic receptor agonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:51:09.312Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic pain"}]},"trialDetails":[{"nctId":"NCT05926414","phase":"","title":"To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2023-09-21","conditions":"Diabetes Mellitus, Type 2","enrollment":15000},{"nctId":"NCT06647888","phase":"","title":"Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia","status":"RECRUITING","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2024-12-03","conditions":"Diabetes Mellitus, Type 2","enrollment":12000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Enavogliflozin 0.3mg/ Metformin1,000mg"],"phase":"phase_2","status":"active","brandName":"Envlomet SR Tablet","genericName":"Envlomet SR Tablet","companyName":"Daewoong Pharmaceutical Co. LTD.","companyId":"daewoong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Envlomet SR Tablet is a medication used to treat type 2 diabetes mellitus, as indicated by ClinicalTrials.gov. The exact mechanism of action of Envlomet SR Tablet is unknown, according to ChEMBL.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}